• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Institute for Myeloma and Bone Cancer Research Adds Two New Board Members

Posted on: Saturday, 23 February 2008, 00:00 CST

The Institute for Myeloma and Bone Cancer Research, an independent non-profit cancer research institute headquartered in Los Angeles, added Roger Fischer and Alvin Dischler to its Board of Directors.

"The two new board members, Roger Fischer and Alvin Dischler, add to our board depth of management," said James R. Berenson, MD, President and CEO for the Institute for Myeloma and Bone Cancer Research. "Roger Fischer's work in the field of healthcare marketing is essential as we promote awareness of our cancer research initiatives. Alvin Dischler's participation on our board will provide additional expertise and business acumen to help us increase our leadership position as an independent cancer research institute."

Roger Fischer is the founder of FischerHealth, a Porter Novelli Company, a member of Omnicom Group (NYSE: OMC). Roger is a 25 year veteran in healthcare marketing and communications strategy.

Alvin L. Dischler was Vice President of May Department Stores. Dischler has been an established force in the business world and has owned and operated a number of small and large businesses throughout Los Angeles including office buildings and industrial parks. Alvin served on the Jewish Federation of Greater Los Angeles' Western Region Board, on the Board of University Synagogue in Brentwood/Los Angeles and was Treasurer and President of Adat Shalom Synagogue in Los Angeles, California.

The Institute for Myeloma and Bone Cancer Research (IMBCR) is an independent, non-profit cancer research institute located in Los Angeles, California. The goal of the Institute is to develop new and cutting-edge therapies to improve the quality of life and longevity of patients with myeloma and other hematologic cancers. www.imbcr.org

Source: Business Wire

More News in this Category